1988
DOI: 10.1016/0002-8703(88)90741-7
|View full text |Cite
|
Sign up to set email alerts
|

Effects of propafenone on ventricular arrhythmias: Double-blind, parallel, randomized, placebo-controlled dose-ranging study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
6
0

Year Published

1991
1991
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(7 citation statements)
references
References 41 publications
1
6
0
Order By: Relevance
“…Propafenone was effective in 17 of 30 patients (57%), a result consistent with those reported previously. [5][6][7][8][9] In addition, the present study showed the equivalent effectiveness of propafenone on the groups with either a positive (n=10, 70%) or bidirectional (n=15, 67%) type of PVC-HR correlation. However, propafenone was not effective in any of the 5 patients (0%) with negative or flat correlations.…”
Section: Discussionsupporting
confidence: 64%
See 2 more Smart Citations
“…Propafenone was effective in 17 of 30 patients (57%), a result consistent with those reported previously. [5][6][7][8][9] In addition, the present study showed the equivalent effectiveness of propafenone on the groups with either a positive (n=10, 70%) or bidirectional (n=15, 67%) type of PVC-HR correlation. However, propafenone was not effective in any of the 5 patients (0%) with negative or flat correlations.…”
Section: Discussionsupporting
confidence: 64%
“…Although many papers have been published regarding the efficacy of propafenone on PVCs, [5][6][7][8][9] few have analyzed its mode of action. 16,17) To our knowledge, the present study is the first report which describes the action of propafenone on PVCs in terms of its heart rate dependency, as well as assessing its effect on CI.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Singh et al examined propafenone's dose‐response relationship in 226 patients with Lown grade 2 premature ventricular contractions (greater than or equal to 30 per hour) documented on 24‐hour Holter recordings. Less than 5% of patients developed first‐degree AV block or intraventricular conduction defect and the occurrence of side effects was not related to dose 23 . In our study, propafenone‐related AV block was reversible in one case and two patients underwent PM implantation due to a persistent AV block.…”
Section: Discussionmentioning
confidence: 42%
“…The antiarrhythmic potential of these AADs for the suppression and termination of VA has been mainly studied until the 1990s. [34][35][36][37] However, in the setting of ACS, these drugs may cause an aggravation of VT/VF. After the publication of the CAST trial that has shown an increased mortality in patients after MI treated with encainide, flecainide, or moricizine as compared with placebo, further research to class IAAD and VA has largely been abandoned.…”
Section: Antiarrhythmic Therapy In Patients With Sustained Ventriculamentioning
confidence: 99%